Back to results
US 2014/0348831 A1Published application
Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same
AssigneeThe Trustees of the University of Pennsylvania
InventorsMark I. Greene, Hongtao Zhang, Geng Zhang
Life of this patent
Estimating the term…
Abstract
Disclosed herein are antibodies that detect a lipid-like antigen on prostate cancer cells and methods of detecting and treating prostate cancer using the same.
Claims3
-14. (canceled)
A method of preferentially inducing cell death in primary or metastatic prostate cancer cells over non-cancerous prostate cells in a human, comprising administering a humanized antibody CDR, Fab, ScFv, or functional fragment thereof derived from the antibody having a variable light chain sequence as set forth in SEQ ID NO:
- 1 and a variable heavy chain sequence as set forth in SEQ ID NO:4.
-33. (canceled)
Dependencies are inferred from the claim text.